Prevalence
Causes
Clinical
features
Investigations
Therapy
Prognosis
|  |  | | Investigations |
-
Blood count
-
haemoglobin a
-
mean cell volume a
-
red cell distribution width
a
Why?
A low MCV makes iron-deficiency more likely
| Patient |
Target Disorder and Reference Standard |
Diagnostic Test |
LR+
(95% CI)
|
Post-test Probability |
anaemia
a
(pre-test probability: 36%)
|
iron-deficiency
anaemia
(bone marrow aspiration)
|
MCV ≤ 70 µm³
|
12
(6.1 to
19)
|
87% |
|
|
|
70 - 75 µm³
|
3.3
(2.0 to
4.7)
|
65% |
|
|
|
75 - 80 µm³
|
1.0
(0.69 to
1.3)
|
36% |
|
|
|
80 - 85 µm³
|
0.91
(0.71 to
1.1)
|
34% |
|
|
|
85 - 90 µm³
|
0.76
(0.56 to
0.96)
|
30% |
|
|
|
≥ 90 µm³
|
0.29
(0.21 to
0.37)
|
14% |
Macrocytosis and hypersegmented neutrophils make cobalamin deficiency more likely
| Patient |
Target Disorder and Reference Standard |
Diagnostic Test |
LR+
(95% CI)
|
Post-test Probability |
LR-
(95% CI)
|
Post-test Probability |
low-serum cobalamin
c
(pre-test probability: 58%)
|
cobalamin deficiency
(response to cobalamin)
|
macrocytosis (MCV > 100 fl)
|
5.4
(2.6 to
11)
|
89% |
0.41
(0.30 to
0.55)
|
37% |
|
|
|
normal white cell count
|
13
(4.9 to
33)
|
95% |
0.15
(0.088 to
0.25)
|
18% |
|
|
|
abnormal blood smear (macrocytosis and hypersegmented neutrophils)
|
25
(3.6 to
180)
|
98% |
0.34
(0.24 to
0.49)
|
36% |
Note:
-
Patients with significant cobalamin deficiency may have neither
significant anaemia nor macrocytosis.
c
|